The Journal of Allergy and Clinical Immunology
Volume 125, Issue 3 , Pages 550-558, March 2010

Social stress and asthma: The role of corticosteroid insensitivity

  • Angela Haczku, MD, PhD

      Affiliations

    • Corresponding Author InformationReprint requests: Angela Haczku MD, PhD, Pulmonary, Allergy and Critical Care Division, Department of Medicine, Translational Research Laboratories, 125 South 31st Street, Philadelphia, PA 19104-3403.
  • ,
  • Reynold A. Panettieri Jr., MD

Pulmonary, Allergy and Critical Care Division, Department of Medicine, University of Pennsylvania, Philadelphia, Pa

Received 17 September 2009; received in revised form 2 November 2009; accepted 5 November 2009. published online 12 February 2010.

Psychosocial stress alters susceptibility to infectious and systemic illnesses and may enhance airway inflammation in asthma by modulating immune cell function through neural and hormonal pathways. Stress activates the hypothalamic-pituitary-adrenal axis. Release of endogenous glucocorticoids, as a consequence, may play a prominent role in altering the airway immune homeostasis. Despite substantial corticosteroid and catecholamine plasma levels, chronic psychosocial stress evokes asthma exacerbations.

Animal studies suggest that social stress induces corticosteroid insensitivity that in part may be a result of impaired glucocorticoid receptor expression and/or function. Such mechanisms likely promote and amplify airway inflammation in response to infections, allergen, or irritant exposure. This review discusses evidence of an altered corticosteroid responsive state as a consequence of chronic psychosocial stress. Elucidation of the mechanisms of stress-induced impairment of glucocorticoid responsiveness and immune homeostasis may identify novel therapeutic targets that could improve asthma management.

Key words: Airway inflammation, psychosocial stress, corticosteroids, innate immune system

Abbreviations used: AP-1, Activator protein 1, GR, Glucocorticoid receptor, GRE, Glucocorticoid response element, HDAC, Histone deacetylase, HPA, Hypothalamic-pituitary-adrenal, NF-κB, Nuclear factor-κB, RU486, Mifepristone (11β-[p-(dimethylamino)phenyl]-17β-hydroxy-17-(1-propynyl)estra-4,9-dien-3-one), SDR, Social disruption stressor, SP, Surfactant protein, TARC, Thymus and activation regulated chemokine

 

 A.H. receives grant support from NIH R01AI055593, R01HL076646, and ALA CI. R.A.P. is supported by the Mind, Body, Brain, and Health Initiative.

 Disclosure of potential conflict of interest: A. Haczku receives research support from Sepracor. R. A. Panettieri receives research support from the NIH-NHLBI and AstraZeneca.

PII: S0091-6749(09)01719-9

doi:10.1016/j.jaci.2009.11.005

The Journal of Allergy and Clinical Immunology
Volume 125, Issue 3 , Pages 550-558, March 2010